Dirk Reuter
Inventor
Stats
- 4 US patents issued
- 9 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 4 US Patents Issued
- 9 US Applications Filed
- 402 Total Citation Count
- Sep 4, 2024 Most Recent Filing
- Apr 2, 1999 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| SOPHION BIOSCIENCE A/S | 1
2 1 | 2002
2003 2005 |
| SEQUENOM, INC. | 1
1 | 1999
2000 |
| AGENA BIOSCIENCE, INC. | 2
2 | 2000
2002 |
Inventor Addresses
| Address | Duration |
|---|---|
| Ballerup, DK | Feb 05, 04 - Sep 29, 05 |
| Gottingen, DE | Jan 08, 04 - Oct 30, 07 |
| HAMBURG, DE | Jan 24, 02 - Jan 24, 02 |
| Hamburg, DE | May 04, 04 - May 04, 04 |
| Norderstedt, DE | Jan 17, 02 - Nov 02, 04 |
| Wedel, DE | Aug 09, 18 - Mar 27, 25 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 2 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 2 |
| B01D: | SEPARATION | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0099,582 | 2025 | TREATMENT OF PATIENTS DIAGNOSED WITH PANCREATIC DUCTAL ADENOCARCINOMA USING MONOCLONAL ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) | 0 |
| 2018/0221,478 | 2018 | TREATMENT OF PATIENTS DIAGNOSED WITH PANCREATIC DUCTAL ADENOCARCINOMA USING USING MONOCLONAL ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) | 0 |
| 7288785 | 2007 | Substrate and method for measuring the electro-physiological properties of cell membranes | 5 |
| 2005/0212,095 | 2005 | Substrate and method for measuring the electrophysiological properties of cell membranes | 3 |
| 6812455 | 2004 | Method and apparatus for MALDI analysis | 7 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.